Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Multiple sclerosis: Bigger brains resist disability in MS.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Leptin and other adipokines in EAE and MS
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
European Charcot Foundation Symposium 2012
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
A rare case of SPG11 mutation with multiple sclerosis.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
MS Research Roundup: January 15, 2014
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »